Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series

Hind RafeiDivision of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

http://orcid.org/0000-0002-5724-4183

Elias Joseph JabbourDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

Hagop KantarjianDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

Kaylyn D. SinicropeDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

Carlos Kamiya-MatsuokaDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

Rohtesh S. MehtaDepartement of Stem Cell Transplant and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Naval G. DaverDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

Tapan M. KadiaDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

Kiran NaqviDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

Jorge CortesDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

Marina KonoplevaDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Correspondence[email protected]

show all

Click to increase image sizeClick to decrease image size

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2019.1633635.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series

Information for

Open access

Opportunities

Help and information

Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series

Potential conflict of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature